JPS6224074B2 - - Google Patents
Info
- Publication number
- JPS6224074B2 JPS6224074B2 JP16646379A JP16646379A JPS6224074B2 JP S6224074 B2 JPS6224074 B2 JP S6224074B2 JP 16646379 A JP16646379 A JP 16646379A JP 16646379 A JP16646379 A JP 16646379A JP S6224074 B2 JPS6224074 B2 JP S6224074B2
- Authority
- JP
- Japan
- Prior art keywords
- lysine
- medium
- strain
- brevibacterium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 34
- 239000004472 Lysine Substances 0.000 claims description 17
- 235000019766 L-Lysine Nutrition 0.000 claims description 16
- 108010030844 2-methylcitrate synthase Proteins 0.000 claims description 11
- 108010071536 Citrate (Si)-synthase Proteins 0.000 claims description 11
- 102000006732 Citrate synthase Human genes 0.000 claims description 11
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 11
- 241000186146 Brevibacterium Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 8
- 241000186216 Corynebacterium Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229930195712 glutamate Natural products 0.000 claims description 4
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 description 16
- 229960003646 lysine Drugs 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960002989 glutamic acid Drugs 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000011218 seed culture Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZXFLCMHBSA-N 5-[(3ar,4r,6as)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@H]2[C@@H](CCCCC(=O)O)SC[C@H]21 YBJHBAHKTGYVGT-ZXFLCMHBSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 238000005273 aeration Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- GHSJKUNUIHUPDF-UHFFFAOYSA-N s-(2-aminoethyl)-l-cysteine Chemical compound NCCSCC(N)C(O)=O GHSJKUNUIHUPDF-UHFFFAOYSA-N 0.000 description 4
- 229940001941 soy protein Drugs 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 229960000344 thiamine hydrochloride Drugs 0.000 description 4
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 4
- 239000011747 thiamine hydrochloride Substances 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 3
- 241000319304 [Brevibacterium] flavum Species 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229940049906 glutamate Drugs 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NDXGCVGKTPQXFA-UHFFFAOYSA-N 3-chloroazepan-2-one Chemical compound ClC1CCCCNC1=O NDXGCVGKTPQXFA-UHFFFAOYSA-N 0.000 description 1
- CXABZTLXNODUTD-UHFFFAOYSA-N 3-fluoropyruvic acid Chemical compound OC(=O)C(=O)CF CXABZTLXNODUTD-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- QLULGSLAHXLKSR-UHFFFAOYSA-N azane;phosphane Chemical compound N.P QLULGSLAHXLKSR-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- YXSPYALQHCEKOH-UHFFFAOYSA-L calcium;azane;carbonate Chemical compound N.[Ca+2].[O-]C([O-])=O YXSPYALQHCEKOH-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- -1 it was cooled Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
この発明はL−リジンの製造法に関する。
本発明者らは、より効率の高いL−リジン生産
菌を誘導すべく研究した結果、ブレビバクテリウ
ム属又は、コリネバクテリウム属に属する従来の
L−リジン生産菌から誘導されたクエン酸合成酵
素(4.1.3.7Citrate oxaloacetate−lyase)の活性
が親株に比べ低下しL−グルタミン酸要求性を有
しない変異株が従来の菌株より高い収率で、L−
リジンを生産することを見い出した。この発明は
この知見にもとづいて完成されるに至つたもので
ある。
本発明において用いられる変異株は、ブレビバ
クテリウム属又はコリネバクテリウム属に属し、
従来L−リジン生産能を有するために必要である
ことが知られている性質即ちホモセリン要求性、
S−(2−アミノエチル)−システイン耐性等の性
質、いいかえればL−リジン生産能を有している
ほかに、クエン酸合成酵素活性の低下した変異株
である。クエン酸合成酵素活性を欠失させるか、
著しく低下させた菌株はグルタミン酸を生育に要
求し、培地中にグルタミン酸を添加しないと生育
ができなくなる。このようにグルタミン酸要求性
を呈する程にクエン酸合成酵素活性が低下した菌
株のL−リジン生産能は、グルタミン酸要求性を
有しない程度に低下した菌株より低く、望しくな
い。
これらの変異株の親株は、従来グルタミン酸生
酸菌として知られているところのブレビバクテリ
ウム属、あるいはコリネバクテリウム属の微生物
である。具体的には例えば以下の菌株がある。
ブレビバクテリウム・デイバリカタム ATCC
14020、
ブレビバクテリウム・フラバム ATCC
14067、
ブレビバクテリウム・ラクトフアーメンタム
ATCC 13869、
ブレビバクテリウム・ロゼウム ATCC
13825、
コリネバクテリウム・アセトアシドフイラム
ATCC 13870、
コリネバクテリウム・リリウム ATCC
15990、
コリネバクテリウム・グルタミクム ATCC
13032。
これらの親株より本発明の変異株を誘導する方
法としては、紫外線照射、N−メチル−N−ニト
ロ−N−ニトロソグアニジン処理等、通常の方法
が適用できる。
以下に本発明の変異株について、その具体的誘
導方法の1例を示す。
(1) ブレビバクテリウム・フラバム ATCC
21475
(AEC〓)を常法によりN−メチル−N′−ニト
ロ−N−ニトロソグアニジンにて処理(250μ
g/ml、30℃で30分)した後、以下に示す最少
培地に、クエン酸又はグルタミン酸0.5%を添
加した培地で生育し、かつ添加しない培地で生
育できないコロニーを、レプリカ法で採取し
た。
最少培地組成
グルコース 2.0g/dl
尿 素 0.25g/dl
硫酸アンモニウム 1.0g/dl
KH2PO4 0.1g/dl
MgSO4・7H2O 0.04g/dl
FeSO4・7H2O 1.0mg/dl
MnSO4・4H2O 1.0mg/dl
ビオチン 50μg/
サイアミン塩酸塩 100μg/
NaC 5.0mg/dl
L−アラニン 50mg/dl
ニコチン酸アミド 0.5mg/dl
PH 7.2
この様にして得られた生育にクエン酸又はグル
タミン酸を必要とする変異株を採取し、この中か
ら更にP.A.Srereの方法(Biochim.Biophys.
Acta、77、P693(1963))で、クエン酸合成酵素
欠失株を選定した。
これらのクエン酸合成酵素欠失株を常法によ
り、N−メチル−N′−ニトロ−N−ニトロソグ
アニジンにて処理(250μg/ml、30℃で、30
分)した後、上記最少培地で、生育できるコロニ
ーを採取した。(従つてこれらの菌株はいずれも
グルタミン酸要求性を有しないものである。)
この様にして得られたクエン酸合成酵素の低下
した復帰変異株であり、かつリジンアナログに耐
性を有する菌の内、L−リジン生産能のすぐれた
変異株として、AJ11507(FERM−P5312)
(AEC〓.CSWeak)を採取した。
又、同様の方法により、コリネバクテリウム・
アセトグルタミクム AJ 11094(FERM−
P3856)AEC〓、Ala-)を親株としてAJ 11508
(FERM−P 5313)(AEC〓、Ala-、CSWeak)
を採取した。
更に同様の方法により、ブレビバクテリウム.
ラクトフアーメンタムAJ11082(FERM−
P3840)AEC〓、CCL〓、Ala-)を親株としてAJ
11509(FERM−P 5314)(AEC〓、CCL〓、
Ala-、CSWeak)を、ブレビバクテリウム.ラク
トフアーメンタム AJ 11273(FERM−P
4547)(AEC〓、CCL〓、Ala-、FPs)を親株と
してAJ 11510(FERM−P 5315)(AEC〓、
CCL〓、Ala-、FPs,CSWeak)を採取した。
AEC〓:S−(2−アミノエチル)−システイ
ン耐性
Ala-:L−アラニン要求性
CCL〓:α−クロロカプロラクタム耐性
FPs:フロロピルビン酸感受性
CSWeak:クエン酸合成酵素活性低下
これらの変異株及びその親株のクエン酸合成酵
素活性を測定した結果を第1表に示す。
This invention relates to a method for producing L-lysine. As a result of research to induce more efficient L-lysine producing bacteria, the present inventors found that citrate synthase derived from conventional L-lysine producing bacteria belonging to the genus Brevibacterium or Corynebacterium (4.1.3.7Citrate oxaloacetate-lyase) activity is lower than that of the parent strain, and the mutant strain, which does not have L-glutamic acid requirement, has a higher yield than the conventional strain.
discovered that it produces lysine. This invention was completed based on this knowledge. The mutant strain used in the present invention belongs to the genus Brevibacterium or Corynebacterium,
Characteristics that are conventionally known to be necessary for having L-lysine production ability, that is, homoserine requirement;
In addition to having properties such as resistance to S-(2-aminoethyl)-cysteine, in other words, the ability to produce L-lysine, it is a mutant strain with reduced citrate synthase activity. Deletion of citrate synthase activity or
Strains with significantly reduced levels require glutamic acid for growth, and cannot grow unless glutamic acid is added to the medium. As described above, the L-lysine production ability of a strain whose citrate synthase activity has been reduced to the extent that it exhibits glutamate auxotrophy is lower than that of a strain whose citrate synthase activity has been reduced to the extent that it does not have glutamate auxotrophy, which is undesirable. The parent strains of these mutant strains are microorganisms of the genus Brevibacterium or Corynebacterium, which are conventionally known as glutamic acid bacteria. Specifically, for example, there are the following strains. Brevibacterium deivaricata ATCC
14020, Brevibacterium flavum ATCC
14067, Brevibacterium lactofamentum
ATCC 13869, Brevibacterium roseum ATCC
13825, Corynebacterium acetoacidophyllum
ATCC 13870, Corynebacterium Lilium ATCC
15990, Corynebacterium glutamicum ATCC
13032. As a method for inducing the mutant strain of the present invention from these parent strains, conventional methods such as ultraviolet irradiation, N-methyl-N-nitro-N-nitrosoguanidine treatment, etc. can be applied. An example of a specific method for inducing the mutant strain of the present invention will be shown below. (1) Brevibacterium flavum ATCC
21475 (AEC〓) was treated with N-methyl-N'-nitro-N-nitrosoguanidine (250μ
g/ml for 30 minutes at 30°C), colonies that grew in the minimal medium shown below to which 0.5% citric acid or glutamic acid was added, and which could not grow in a medium without the addition, were collected using the replica method. Minimum medium composition Glucose 2.0g/dl Urea 0.25g/dl Ammonium sulfate 1.0g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1.0mg/dl MnSO 4・4H 2 O 1.0mg/dl Biotin 50μg/ Thiamine hydrochloride 100μg/ NaC 5.0mg/dl L-alanine 50mg/dl Nicotinamide 0.5mg/dl PH 7.2 Citric acid or glutamic acid is required for the growth thus obtained. Collect the mutant strain and use the PASrere method (Biochim.Biophys.
Acta, 77, P693 (1963)), a citrate synthase-deficient strain was selected. These citrate synthase-deficient strains were treated with N-methyl-N'-nitro-N-nitrosoguanidine (250 μg/ml, 30°C, 30°C,
After 5 minutes), colonies that could grow were collected in the above minimal medium. (Thus, none of these strains has glutamate auxotrophy.) This is a revertant strain with reduced citrate synthase and is one of the strains that is resistant to lysine analogs. , AJ11507 (FERM-P5312) as a mutant strain with excellent L-lysine production ability.
(AEC〓.CS Weak ) was collected. In addition, by the same method, Corynebacterium
Acetoglutamicum AJ 11094 (FERM−
P3856) AEC〓, Ala - ) as parent stock AJ 11508
(FERM-P 5313) (AEC〓, Ala - , CS Weak )
was collected. Furthermore, by the same method, Brevibacterium.
Lactofermentum AJ11082 (FERM−
P3840) AEC〓, CCL〓, Ala - ) as parent stock AJ
11509 (FERM-P 5314) (AEC〓, CCL〓,
Ala- , CS Weak ), Brevibacterium. Lactofermentum AJ 11273 (FERM-P
AJ 11510 (FERM-P 5315 ) (AEC〓,
CCL〓, Ala - , FP s , CS Weak ) were collected. AEC〓: S-(2-aminoethyl)-cysteine resistance Ala - : L-alanine requirement CCL〓: α-chlorocaprolactam resistance FP s : Fluoropyruvate sensitivity CS Weak : Decreased citrate synthase activity These mutants Table 1 shows the results of measuring the citrate synthase activity of this strain and its parent strain.
【表】【table】
【表】
実験方法:Biochim.Biophys、Acta、77、693
に記載の方法に準じて行つた。
酵素標品は次のようにして調製した。
グルコーズ10g/dl、硫安アンモニウム4.5g/
dl、KH2PO4 0.1g/dl、MgSO4・7H2O 0.04g/
dl、FeSO4・7H2O 1.0mg/dl、MnSO4・4H2O
1.0mg/dl、ビオチン500μg/、サイアシン・
塩酸塩200μg/、大豆タンパク塩酸加水分解
液濃縮物、(総窒素7%)1.5mg/dl、及び炭酸カ
ルシウム(別殺菌添加)5g/dl、を含みPH8.0に
調節した培地を用いて31℃、48時間振とう培養
後、集菌した。トリス・塩酸塩バツフアー(PH
7.5、0.56M)で2回洗浄し、超音波破砕
(10kc、5分間)後12000、30分遠沈し、破砕物
を除いた。
上清は、「セフアデツクスG−10」を用い、低
分子物質を除き、ゲル濾過した液を酵素標品とし
て用いた。
これらの微生物をもちいてL−リジンを生産せ
しめるには、とくに困難はなく、炭素源、窒素
源、無機塩類、更に必要により有機微量栄養素を
含有する通常の栄養培地をもちいて常法によりお
こなう。もちいられる炭素源としては、グルコー
ズ、シユークローズ、糖蜜、デンプン加水分解液
などの糖類、酢酸、プロピオン酸、安息香酸など
の有機酸、エタノール、プロパノールなどのアル
コール類、などが使用できる。
窒素源としては、アンモニウム塩、(硫安、硝
安、塩安、リン安など)尿素、アンモニア水、ア
ンモニアガスその他が使用できる。
又、栄養要求性を示す変異株を用いる等、必要
があればビタミン、アミノ酸等、更にこれらを含
有する大豆タンパク質加水分解物、コーン・ステ
イープ・リカー、酵母エキス、あるいはペプトン
などの有機微量栄養素を培地に添加する。
培養は好気的条件下で行うのが良く、24〜37
℃、PH5.0〜9.0で行えば最も好ましい結果が得ら
れる。PHの調整には無機あるいは有機の酸あるい
は、アルカリ、更には尿素、炭酸カルシウムアン
モニアガスなどを使用することができる。かくし
て2〜7日間も培養を行えば、培地中には著量の
L−リジンが生成蓄積される。
発酵液からのL−リジンの採取は、通常、イオ
ン交換樹脂法、その他の公知の方法を組み合わせ
ることによりおこなわれ、培地の種類によつては
直接晶析法により行なうことも可能である。
実施例 1
下記の組成の培地を20ml宛、500ml容振とうフ
ラスコに分注し、110℃にて5分間蒸気殺菌し
た。
培地組成
グルコース 2.0g/dl
硫酸アンモニウム 4.5g/dl
KH2PO4 0.1g/dl
MgSO4・7H2O 0.04g/dl
FeSO4・7H2O 1.0mg/dl
MnSO4・4H2O 1.0mg/dl
ビオチン 500μg/
サイアミン塩酸塩 200μg/
グルタミン酸ナトリウム 0.25g/dl
大豆タンパク塩酸加水分解液濃縮物 1.5mg/dl
(総窒素 7%)
炭酸カルシウム(別殺菌添加) 5.0g/dl
PH 7.0
上記の如く調製したフラスコ中の培地に、あら
かじめグルコース・ブイヨンスラント上で生育せ
しめて第2表に示す菌株を1白金耳づつ接種し、
それらを31℃にて72時間振とう培養した。
72時間培養後の培地中のL−リジン生成量を、
酸性−銅ニンヒドリン反応を用いる比色法によつ
て行なつた。結果を第2表に示す。[Table] Experimental method: Biochim.Biophys, Acta, 77, 693
This was carried out according to the method described in . Enzyme preparations were prepared as follows. Glucose 10g/dl, ammonium ammonium sulfate 4.5g/
dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O 0.04g/
dl, FeSO 4・7H 2 O 1.0 mg/dl, MnSO 4・4H 2 O
1.0mg/dl, biotin 500μg/, cyacin.
Using a medium adjusted to pH 8.0 containing 200 μg/dl of hydrochloride, 1.5 mg/dl of soy protein hydrolyzate concentrate (7% total nitrogen), and 5 g/dl of calcium carbonate (added separately for sterilization). After shaking culture at ℃ for 48 hours, bacteria were collected. Tris-hydrochloride buffer (PH
7.5 and 0.56M) twice, and after ultrasonic disruption (10 kc, 5 minutes), centrifugation was performed at 12,000 rpm for 30 minutes to remove the crushed materials. The supernatant was gel-filtered using "Sephadex G-10" to remove low-molecular substances, and the liquid was used as an enzyme preparation. There is no particular difficulty in producing L-lysine using these microorganisms, and it is carried out in a conventional manner using a conventional nutrient medium containing a carbon source, a nitrogen source, inorganic salts, and, if necessary, organic trace nutrients. Examples of carbon sources that can be used include sugars such as glucose, sucrose, molasses, and starch hydrolyzate; organic acids such as acetic acid, propionic acid, and benzoic acid; and alcohols such as ethanol and propanol. As the nitrogen source, ammonium salts, urea (ammonium sulfate, ammonium nitrate, ammonium chloride, ammonium phosphorus, etc.), aqueous ammonia, ammonia gas, and others can be used. In addition, if necessary, by using mutant strains that exhibit nutritional auxotrophy, vitamins, amino acids, etc., and organic micronutrients such as soybean protein hydrolyzate, corn staple liquor, yeast extract, or peptone containing these can be added. Add to medium. Cultivation is best done under aerobic conditions, 24-37
The most favorable results will be obtained if the reaction is carried out at ℃ and pH 5.0 to 9.0. To adjust the pH, inorganic or organic acids or alkalis, as well as urea, calcium carbonate ammonia gas, etc. can be used. Thus, if the culture is continued for 2 to 7 days, a significant amount of L-lysine will be produced and accumulated in the medium. Collection of L-lysine from the fermentation broth is usually carried out by a combination of the ion exchange resin method and other known methods, and depending on the type of medium, it can also be carried out by direct crystallization. Example 1 20 ml of a medium having the composition shown below was dispensed into a 500 ml shaking flask and steam sterilized at 110°C for 5 minutes. Medium composition Glucose 2.0g/dl Ammonium sulfate 4.5g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1.0mg/dl MnSO 4・4H 2 O 1.0mg/dl Biotin 500μg/thiamine hydrochloride 200μg/sodium glutamate 0.25g/dl Soy protein hydrolysis solution concentrate 1.5mg/dl (total nitrogen 7%) Calcium carbonate (separate sterilization added) 5.0g/dl PH 7.0 Prepared as above Inoculate the culture medium in a flask with one platinum loopful of the strains shown in Table 2, which have been grown on glucose bouillon slant in advance, and
They were cultured with shaking at 31°C for 72 hours. The amount of L-lysine produced in the medium after 72 hours of culture,
It was carried out by a colorimetric method using an acidic-copper ninhydrin reaction. The results are shown in Table 2.
【表】【table】
【表】
AJ11510株の培養終了液1.5を上記と同様の
方法で調整し、遠心分離によつて、菌体及びカル
シウム塩を除いた。上清液1を、強酸性イオン
交換樹脂(「アンバーライトIR−1200H型)に通
過させ、L−リジンを吸着させた。ついで、3%
アンモニア水で、吸着したL−リジンを溶出し、
溶出液を減圧濃縮した。濃縮液に塩酸を添加した
のち冷却し、L−リジンをL−リジン塩酸塩第2
水加物として析出させ、結晶4.1gを得た。
実施例 2
ブレビバクテリウム・フラバムAJ 11507及び
その親株ATCC 21475をそれぞれスラント上より
1白金耳かきとり、次記種培養培地50mlに接種
し、18時間、31℃にて通気撹拌培養をおこなつて
種培養液を調製した。
種培養培地組成:
グルコーズ 1.5g/dl
硫酸アンモニウム 0.3g/dl
尿 素 0.1g/dl
KH2PO4 0.1g/dl
MgSO4・7H2O 0.04g/dl
FeSO4・7H2O 1.0mg/dl
MnSO4・4H2O 1.0mg/dl
ビオチン 50μg/
サイアミン塩酸塩 200μg/
グルタミン酸ナトリウム 0.25g/dl
大豆タンパク塩酸加水分解液濃縮物 2mg/dl
(総窒素 7%)
PH 7.5
一方、1容小型ガラス製ジヤー・フアーメン
ターに次記組成より成る主発酵培地を300ml宛分
注し、常法により殺菌した。
これらに上記の種培養液をそれぞれ15ml宛接種
し、31℃にて通気撹拌培養を開始した。
主発酵培地組成:
グルコーズ 2g/dl
硫酸アンモニウム 0.5g/dl
尿素 0.2g/dl
KH2PO4 0.1g/dl
MgSO4・7H2O 0.04g/dl
FeSO4・7H2O 1mg/dl
MnSO4・4H2O 1mg/dl
ビオチン 50μg/
サイアミン塩酸塩 50μg/
ニコチン酸アミド 1mg/
大豆タンパク塩酸加水分解液濃縮物 3mg/dl
(総窒素 7%)
PH 7.2
培養液中に、酢酸と酢酸アンモニウムとの混合
液を培地のPHを7.2〜8.0の間に保つようにして添
加し、31〜33℃で、55時間培養を行なつた。結果
を第3表に示す。[Table] 1.5 hours of the cultured solution of AJ11510 strain was prepared in the same manner as above, and the bacterial cells and calcium salts were removed by centrifugation. The supernatant liquid 1 was passed through a strongly acidic ion exchange resin (Amberlite IR-1200H type) to adsorb L-lysine.
Elute the adsorbed L-lysine with aqueous ammonia,
The eluate was concentrated under reduced pressure. After adding hydrochloric acid to the concentrate, it was cooled, and L-lysine was converted into L-lysine hydrochloride No. 2.
It was precipitated as a hydrate to obtain 4.1 g of crystals. Example 2 One platinum loop of Brevibacterium flavum AJ 11507 and its parent strain ATCC 21475 were each scraped off from the top of the slant, inoculated into 50 ml of the following seed culture medium, and cultured with aeration and stirring at 31°C for 18 hours. A culture solution was prepared. Seed culture medium composition: Glucose 1.5g/dl Ammonium sulfate 0.3g/dl Urea 0.1g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1.0mg/dl MnSO 4・4H 2 O 1.0mg/dl Biotin 50μg/ Thiamine hydrochloride 200μg/ Sodium glutamate 0.25g/dl Soy protein hydrolysis solution concentrate 2mg/dl (Total nitrogen 7%) PH 7.5 Meanwhile, 1 volume small glass jar - Dispense 300 ml of the main fermentation medium with the following composition into a fermentor and sterilize it using a conventional method. Each of these was inoculated with 15 ml of the above seed culture solution, and culture with aeration and stirring was started at 31°C. Main fermentation medium composition: Glucose 2g/dl Ammonium sulfate 0.5g/dl Urea 0.2g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1mg/dl MnSO 4・4H 2 O 1mg/dl Biotin 50μg/ Thiamine hydrochloride 50μg/ Nicotinamide 1mg/ Soy protein hydrolyzate hydrolyzate concentrate 3mg/dl (Total nitrogen 7%) PH 7.2 A mixture of acetic acid and ammonium acetate in the culture medium was added so as to maintain the pH of the medium between 7.2 and 8.0, and culture was carried out at 31 to 33°C for 55 hours. The results are shown in Table 3.
【表】
実施例 3
ブレビバクテリウム・フラバムAJ 11507及び
その親株であるATCC 21475を、それぞれ1白金
耳づつ実施例2に示した種培養培地(但し、酢酸
アンモニウムの代りにエチルアルコールを0.5g/
ml使用し、さらに尿素を0.3g/dlに変更した)50
mlに接種し、18時間、31℃にて通気撹拌培養を行
なつた。一方、1容の小型ガラス製ジヤーフア
ーメンターに実施例2に示した主発酵培地(但
し、グルコーズ濃度は、1g/dlになるように
し、酢酸アンモニウムの代りにエチルアルコール
を1g/dl、硫酸アンモニウムを、0.5g/dl添加し
た。)を300ml宛分注し、殺菌した。これらに上記
の種培養液をそれぞれ15ml宛接種し、31℃にて通
気撹拌培養を開始した。
培養中、PHが低下したときに、アンモニアガス
によりPH7.2〜8.2の間に保持した。エチルアルコ
ールは、その消費をガスクロマトグラフで定量
し、その培地中の濃度が0.3%前後に減少したと
き添加した。31〜33℃で、48時間培養したとこ
ろ、それぞれの培養液中には、第4表に示す量の
L−リジンの蓄積された。[Table] Example 3 One loopful each of Brevibacterium flavum AJ 11507 and its parent strain ATCC 21475 were grown in the seed culture medium shown in Example 2 (however, 0.5 g/ml of ethyl alcohol was added instead of ammonium acetate).
ml and further changed urea to 0.3g/dl) 50
ml and cultured with aeration at 31°C for 18 hours. On the other hand, in a 1-volume small glass jar fermenter, the main fermentation medium shown in Example 2 (however, the glucose concentration was adjusted to 1 g/dl, 1 g/dl of ethyl alcohol instead of ammonium acetate, and 1 g/dl of ammonium sulfate) 0.5g/dl) was dispensed into 300ml volumes and sterilized. Each of these was inoculated with 15 ml of the above seed culture solution, and culture with aeration and stirring was started at 31°C. During culture, when the pH decreased, the pH was maintained between 7.2 and 8.2 with ammonia gas. Ethyl alcohol was added when its consumption in the medium was determined by gas chromatography and its concentration in the medium decreased to around 0.3%. When cultured at 31-33°C for 48 hours, L-lysine was accumulated in each culture solution in the amount shown in Table 4.
Claims (1)
ウム属に属し、クエン酸合成酵素
(4.1.3.7Citrate oxaloacetate−lyase)の活性
が、親株に比べ50%ないし95%低下し、かつL−
グルタミン酸要求性を有しないL−リジン生産能
を有する変異株を培養し生成蓄積したL−リジン
を採取することを特徴とするL−リジンの製造方
法。1 Belongs to the genus Brevibacterium or Corynebacterium, has 50% to 95% lower activity of citrate synthase (4.1.3.7Citrate oxaloacetate-lyase) than the parent strain, and has L-
1. A method for producing L-lysine, which comprises culturing a mutant strain having the ability to produce L-lysine without requiring glutamate, and collecting L-lysine produced and accumulated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16646379A JPS5688799A (en) | 1979-12-21 | 1979-12-21 | Preparation of l-lysine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16646379A JPS5688799A (en) | 1979-12-21 | 1979-12-21 | Preparation of l-lysine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5688799A JPS5688799A (en) | 1981-07-18 |
JPS6224074B2 true JPS6224074B2 (en) | 1987-05-26 |
Family
ID=15831857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16646379A Granted JPS5688799A (en) | 1979-12-21 | 1979-12-21 | Preparation of l-lysine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5688799A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012157699A1 (en) | 2011-05-18 | 2012-11-22 | 味の素株式会社 | Immunostimulant for animals, feed containing same, and method for manufacturing same |
WO2014185430A1 (en) | 2013-05-13 | 2014-11-20 | 味の素株式会社 | Method for manufacturing l-amino acid |
WO2015060391A1 (en) | 2013-10-23 | 2015-04-30 | 味の素株式会社 | Method for producing target substance |
EP3385389A1 (en) | 2017-04-03 | 2018-10-10 | Ajinomoto Co., Inc. | Method for producing l-amino acid from fructose |
WO2020071538A1 (en) | 2018-10-05 | 2020-04-09 | Ajinomoto Co., Inc. | Method for producing target substance by bacterial fermentation |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1354051A1 (en) * | 2001-01-25 | 2003-10-22 | Degussa AG | Novel nucleotide sequences that encode the cite gene |
US20030113879A1 (en) | 2001-06-06 | 2003-06-19 | Mike Farwick | Novel nucleotide sequences coding the citE gene |
JP2005065641A (en) * | 2003-08-27 | 2005-03-17 | Mitsubishi Chemicals Corp | Method for producing non-amino organic acid |
-
1979
- 1979-12-21 JP JP16646379A patent/JPS5688799A/en active Granted
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012157699A1 (en) | 2011-05-18 | 2012-11-22 | 味の素株式会社 | Immunostimulant for animals, feed containing same, and method for manufacturing same |
WO2014185430A1 (en) | 2013-05-13 | 2014-11-20 | 味の素株式会社 | Method for manufacturing l-amino acid |
WO2015060391A1 (en) | 2013-10-23 | 2015-04-30 | 味の素株式会社 | Method for producing target substance |
EP3385389A1 (en) | 2017-04-03 | 2018-10-10 | Ajinomoto Co., Inc. | Method for producing l-amino acid from fructose |
WO2020071538A1 (en) | 2018-10-05 | 2020-04-09 | Ajinomoto Co., Inc. | Method for producing target substance by bacterial fermentation |
Also Published As
Publication number | Publication date |
---|---|
JPS5688799A (en) | 1981-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3151073B2 (en) | Production of amino acids by fermentation | |
JPS6236673B2 (en) | ||
JP2817155B2 (en) | Production method of L-arginine by fermentation method | |
JPH02186994A (en) | Production of l-amino acid by fermentation | |
JP2810697B2 (en) | Method for producing aromatic amino acids | |
JP3016883B2 (en) | Method for producing 5'-xanthylic acid by fermentation method | |
JPH0362394B2 (en) | ||
JPS6257315B2 (en) | ||
US3871960A (en) | Method of producing l-lysine by fermentation | |
JPH0362395B2 (en) | ||
JP2876739B2 (en) | Production method of L-lysine by fermentation method | |
JPS6224074B2 (en) | ||
US3893888A (en) | Fermentative production of l-valine | |
JP2578492B2 (en) | Method for producing L-threonine by fermentation method | |
US5188947A (en) | Process and microorganism for producing l-ornithine by corynebacterium, brevibacterium, or athrobacter | |
JP3006929B2 (en) | Production method of L-valine by fermentation method | |
JPS6236672B2 (en) | ||
JP2817172B2 (en) | Production of L-lysine by fermentation | |
JPH0644871B2 (en) | Fermentation method for producing L-leucine | |
KR910008636B1 (en) | Process for producing l - arginine | |
JPH0665314B2 (en) | Fermentation method for producing L-valine | |
JPS6362199B2 (en) | ||
JP2995816B2 (en) | Production method of L-lysine by fermentation method | |
JPH0561914B2 (en) | ||
JPS6236679B2 (en) |